Vaxxinity, Inc. Class A Common Stock
VAXX
VAXX was delisted on the 8th of May, 2024.
1 hedge funds and large institutions have $43 invested in Vaxxinity, Inc. Class A Common Stock in 2026 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NS
NBC Securities
Birmingham,
Alabama
|
+$43 |
Top Sellers
VAXX Hedge Fund Activity: Q1 2026 in Review
1 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in Vaxxinity, Inc. Class A Common Stock (VAXX) for Q1 2026, worth a combined $43.
Buyers outnumbered sellers: 1 fund opened new VAXX positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was NBC Securities, opening a new position worth an estimated $43.
- 1 institutional investor held Vaxxinity, Inc. Class A Common Stock (VAXX) as of Q1 2026, up from 0 in Q4 2025.
- Funds reported $43 of Vaxxinity, Inc. Class A Common Stock stock for Q1 2026.
- 1 fund opened new Vaxxinity, Inc. Class A Common Stock positions in Q1 2026 and 0 closed out, a net change of +1 holder.
- The largest Vaxxinity, Inc. Class A Common Stock buyer in Q1 2026 was NBC Securities, an estimated $43 added.
Based on aggregated 13F filings for Q1 2026.